Doxazosin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions:   Overactive Bladder;   Benign Prostatic HyperplasiaIntervention:   Drug: doxazosin plus tolterodine SRSponsors:   Samsung Medical Center;   Samsung Medical CenterRecruiting - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2009 Category: Research Source Type: clinical trials

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions:   Overactive Bladder;   Benign Prostatic HyperplasiaIntervention:   Drug: doxazosin plus tolterodine SRSponsor:   Samsung Medical CenterRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2009 Category: Research Source Type: clinical trials